Basilea Pharmaceutica
BSLN.SW
#6397
Rank
C$1.08 B
Marketcap
C$88.57
Share price
0.78%
Change (1 day)
36.64%
Change (1 year)

Earnings for Basilea Pharmaceutica (BSLN.SW)

Earnings in 2024: C$92.16 Million

According to Basilea Pharmaceutica's latest financial reports the company's current earnings are C$0.23 Billion. In 2024 the company made an earning of C$92.16 Million, an increase over its 2023 earnings that were of C$17.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Basilea Pharmaceutica from 2002 to 2024

Annual earnings

Year Earnings Change
2024C$92.16 M436.2%
2023C$17.18 M-5.02%
2022C$18.09 M-276.18%
2021-C$10.28 Million-55.31%
2020-C$22.99 Million-28%
2019-C$31.93 Million-27.06%
2018-C$43.77 Million62.13%
2017-C$27 Million-60.94%
2016-C$69.11 Million-19.67%
2015-C$86.03 Million48.25%
2014-C$58.03 Million12.95%
2013-C$51.38 Million-35.16%
2012-C$79.24 Million-5.75%
2011-C$84.07 Million-152.57%
2010C$0.15 B-199.59%
2009-C$0.17 Billion-15.54%
2008-C$0.2 Billion22.84%
2007-C$0.16 Billion60.07%
2006-C$96.7 Million85.69%
2005-C$52.08 Million-43.04%
2004-C$91.43 Million47.04%
2003-C$62.18 Million-38.94%
2002-C$0.11 Billion